phosphatidylcholines has been researched along with aromasil in 2 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (aromasil) | Trials (aromasil) | Recent Studies (post-2010) (aromasil) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 897 | 245 | 492 |
Protein | Taxonomy | phosphatidylcholines (IC50) | aromasil (IC50) |
---|---|---|---|
Aromatase | Homo sapiens (human) | 0.1701 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Betageri, GV; Hiremath, PS; Soppimath, KS | 1 |
Alam Rizvi, MM; Amin, S; Mir, SR; Perwez, A; Rizwanullah, M | 1 |
2 other study(ies) available for phosphatidylcholines and aromasil
Article | Year |
---|---|
Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine.
Topics: Absorption; Administration, Oral; Androstadienes; Animals; Aromatase Inhibitors; Caco-2 Cells; Cholesterol; Drug Carriers; Humans; Intestines; Liposomes; Membranes, Artificial; Particle Size; Permeability; Phosphatidylcholines; Phospholipids; Rats; Rats, Sprague-Dawley; Solubility | 2009 |
Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization,
Topics: Androstadienes; Antineoplastic Agents; Biomimetic Materials; Cell Survival; Drug Carriers; Drug Compounding; Drug Liberation; Drug Stability; Factor Analysis, Statistical; Fluorescent Dyes; Gastric Juice; Humans; Kinetics; Liposomes; MCF-7 Cells; Nanoparticles; Phosphatidylcholines; Polyesters; Rhodamines; Vitamin E | 2021 |